Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry
Diabetes mellitus (DM) is associated with a high rate of major adverse cardiac events (MACE) after de novo coronary artery percutaneous coronary intervention (PCI). Whether patients with DM undergoing PCI for in-stent restenosis (ISR) experience a similar heightened risk of MACE is not known. Hence, we sought to compare the clinical outcomes of patients with and without DM undergoing PCI for ISR.
Source: International Journal of Cardiology - Category: Cardiology Authors: Richard Tanner, Serdar Farhan, Gennaro Giustino, Samantha Sartori, Yihan Feng, Amit Hooda, Manish Vinayak, George Dangas, Roxana Mehran, Annapoorna S. Kini, Samin K. Sharma Source Type: research
More News: Angioplasty | Cardiology | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Percutaneous Coronary Intervention